We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
426
Baidu
BIDU
$35.7B
$3.55M 0.02%
23,836
-9,412
-28% -$1.47M
KMI icon
427
Kinder Morgan
KMI
$70.9B
$3.53M 0.02%
222,356
-928,065
-81% -$15.4M
RF icon
428
Regions Financial
RF
$26.4B
$3.51M 0.02%
160,963
-1,253,050
-89% -$28.7M
CIT
429
DELISTED
CIT Group Inc.
CIT
$3.45M 0.02%
67,220
+11,268
+20% +$574K
NIO icon
430
NIO
NIO
$11.9B
$3.44M 0.02%
108,747
+9,244
+9% +$340K
ROP icon
431
Roper Technologies
ROP
$40.4B
$3.44M 0.02%
6,991
-294
-4% -$140K
ES icon
432
Eversource Energy
ES
$28.1B
$3.43M 0.02%
37,666
-1,133
-3% -$97.5K
CERE
433
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$3.42M 0.02%
+105,599
New +$3.73M
CCK icon
434
Crown Holdings
CCK
$13B
$3.41M 0.02%
30,820
+7,590
+33% +$807K
ALL icon
435
Allstate
ALL
$70.6B
$3.39M 0.02%
28,829
+922
+3% +$109K
FAST icon
436
Fastenal
FAST
$54.8B
$3.38M 0.02%
105,616
-7,748
-7% -$228K
LII icon
437
Lennox International
LII
$15B
$3.34M 0.02%
10,293
+1,075
+12% +$336K
MASI
438
DELISTED
Masimo
MASI
$3.32M 0.02%
11,341
-9,749
-46% -$2.78M
VMI icon
439
Valmont Industries
VMI
$8.86B
$3.3M 0.02%
13,174
– –
WBA
440
DELISTED
Walgreens Boots Alliance
WBA
$3.29M 0.02%
63,173
-5,357
-8% -$259K
FITB
441
Fifth Third Bancorp
FITB
$51.3B
$3.29M 0.02%
75,468
-5,447
-7% -$238K
YETI icon
442
Yeti Holdings
YETI
$3.87B
$3.27M 0.02%
39,526
-1,313
-3% -$121K
AIG icon
443
American International
AIG
$42.5B
$3.26M 0.02%
57,337
+972
+2% +$55.4K
WRB icon
444
W.R. Berkley
WRB
$28.1B
$3.25M 0.02%
88,742
-11,523
-11% -$409K
NVR icon
445
NVR
NVR
$17.1B
$3.24M 0.02%
549
+319
+139% +$1.68M
TROW icon
446
T. Rowe Price
TROW
$25.5B
$3.19M 0.02%
16,246
-933
-5% -$190K
SYY icon
447
Sysco
SYY
$40.8B
$3.17M 0.02%
40,424
-703
-2% -$54.1K
WMB icon
448
Williams Companies
WMB
$85.8B
$3.17M 0.02%
121,671
+20,896
+21% +$577K
SKX
449
DELISTED
Skechers
SKX
$3.16M 0.02%
+72,876
New +$3.27M
BSX icon
450
Boston Scientific
BSX
$68.4B
$3.16M 0.02%
74,371
-8,821
-11% -$371K
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.